Annexon, Inc.

Patents = 9

Trademarks = 7

Forward Citations = 29

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

15 inventors (with patents filed for the assignee):

Annexon is a clinical-stage biopharmaceutical company focused on developing novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. The company is leveraging its proprietary anti-C1q antibody platform to address unmet medical needs in a broad spectrum of autoimmune and neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com